Lasker Award of this Year Was Announced

2017 Lasker Award 

Lasker Award, which is sometimes referred to as “America’s Nobels”, was announced on September 6th. Three scientists were awarded for their outstanding contributions to human papilloma virus (HPV) vaccine and related discoveries in cell growth and metabolic regulation.

23The US Lasker Foundation announced that this year’s Lasker Award for Clinical Medicine Research Awards were awarded to John Schiller and Douglas Lowy from the National Cancer Institute on the grounds that their work enabled the development of human papillomavirus (HPV) vaccines, which prevent cervical cancer and other tumors.

The Foundation said that HPV could cause female cervical cancer and other malignant tumors. Lowy and Schiller have taken a bold while appropriate way to design the blueprints for several safe and effective vaccines that were expected to help reduce the incidence and mortality of cervical cancer.

12This year’s Lasker Award for Basic Medicine Research was awarded to Michael Hall from University of Basel on the grounds that he discovered the nutrient-activated TOR protein and its important role in cell growth and metabolism regulation. The destruction of TOR protein can lead to many diseases such as diabetes, cancer and other diseases associated with other series of age-related diseases.

In addition, this year’s Lasker Award of Public Service Award was awarded to the Planned Parenthood Federation of America to reward its work in providing millions of women with the necessary health and reproductive health services in the past century.

About Lasker Award

The Lasker Award was created by Albert Lasker, father of modern advertising, in 1946 in recognition of scientists, medical researcher and public service personnel or institutions who have made great contributions in the field of medical research. Eighty Lasker laureates have received a Nobel Prize.

About Author

Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early drug discovery and development, such as itc services, antibody engineering, antibody production, etc.

Published by:

creativebiolabs

Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early drug discovery and drug development. As a trusted provider of the most cost-effective outsourcing solutions, Creative Biolabs has been working for a large number of satisfied clients from biotechnology and pharmaceutical companies as well as government and academic research laboratories all over the world. Creative Biolabs was founded by scientists who are dedicated to the conquering of cancer. We believe to build up a custom-service-centered business model is important for optimizing the drug development process, leveraging accessible resources, and forming a team of various background to conduct drug discovery in future. Our commitment to this long-term goal motivates us to deliver the highest quality results to our clients with speed.

Categories biotech newsTags , , , , , Leave a comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s